GlassScriptPhysician profile
Andrew B Silva
NPI 1972569192
$7,440.21
in general payments reported to CMS, 2019-2025
23 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what 87% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $88.09 · 2021: $225 · 2022: $4,172 · 2023: $775 · 2024: $747 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,664.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,059.13 | 2022-2023 | Propel |
| Medical Device Business Services, INC. | $959.57 | 2022 | |
| Genzyme Corporation | $604.06 | 2019-2025 | |
| Acclarent, INC | $485.90 | 2022-2024 | Trudi Nav Cable |
| Integra Lifesciences Corporation | $361.02 | 2021-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $322.57 | 2023-2025 | Dupixent, Libtayo |
| Optinose US, INC. | $248.06 | 2019-2024 | |
| Glaxosmithkline, LLC. | $222.99 | 2021-2024 | Nucala |
| Inspire Medical Systems, INC. | $218.32 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $181.10 | 2025 | Tezspire |
| Kowa Pharmaceuticals America, INC. | $109.89 | 2022-2023 | Seglentis |
| Aerin Medical INC. | $88.33 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $86.02 | 2024 | Exparel |
| Stryker Corporation | $77.46 | 2019-2025 | Audion Et Dilation System |
| Neurent Medical Limited | $76.54 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $68.25 | 2019 | |
| Smith+Nephew, INC. | $58.17 | 2020-2022 | |
| Supreme Orthopedic Systems, LLC | $52.95 | 2023 | |
| Baxter Healthcare | $46.81 | 2025 | |
| Innovation Technologies INC | $43.10 | 2023 | Irrisept |
| Cochlear Americas | $35.51 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Alk-Abello, INC | $20.44 | 2021 | |
| Checkpoint Surgical, INC | $14.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.